Detaint, Delphine <br/><br/>
Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome.  [electronic resource] 

 -  Archives of cardiovascular diseases  May 2010 
 - 317-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1875-2128 
<br/><br/><label>Standard No.: </label>10.1016/j.acvd.2010.04.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Animals<br/>Aortic Aneurysm--diagnostic imaging<br/>Disease Models, Animal<br/>Double-Blind Method<br/>France<br/>Humans<br/>Losartan--therapeutic use<br/>Marfan Syndrome--complications<br/>Mice<br/>Placebo Effect<br/>Research Design<br/>Treatment Outcome<br/>Ultrasonography